Twice Against Thrice-weekly Hemodialysis (TATH)
Twice-Against Thrice-weekly Hemodialysis: the TATH Trial
Sponsor: Saint-Joseph University
Terminated
Very slow recruitment due to many challenges: 1-COVID-19 pandemic 2-Several units did not include their patients, 3-Many nephrologists left the country, 4-Severe economic crisis
Other terminated trials from Saint-Joseph University
This NA trial investigates Hemodialysis Complication and is currently terminated or withdrawn. Saint-Joseph University leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Oct 2021 — Nov 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — Nov 2020 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2018 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Saint-Joseph University
For direct contact, visit the study record on ClinicalTrials.gov .